Viking Global Performance LLC

Number of records: 40
SEC FilingCompany/StockTrade DateTransactionSharesAvg. PriceTotal% HoldingsGain/Loss
02-Jul-19 5:13 PM
View: 
Adaptive Biotechnologies Corp (ADPT) 01-Jul-19Conversion
Duplicate
36,731,600----2578%
1.43M to 38.16M
02-Jul-19 5:13 PM
View: 
Adaptive Biotechnologies Corp (ADPT) 01-Jul-19Purchase
Duplicate
250,000$20.00$5,000,000.00< 1%
38.16M to 38.41M
28-Jun-19 7:02 PM
View: 
Bridgebio Pharma, Inc. (BBIO) 27-Jun-19Conversion
Duplicate
21,915,100----100%
0 to 21.92M
28-Jun-19 7:02 PM
View: 
Bridgebio Pharma, Inc. (BBIO) 27-Jun-19Purchase
Duplicate
4,705,900$17.00$80,000,304.0021%
21.92M to 26.62M
19-Jun-19 6:29 PM
View: 
Urovant Sciences Ltd. (UROV) 19-Jun-19Market Purchase (Planned)
Duplicate
4,957$8.17$40,495.20< 1%
22.86M to 22.86M
(8%)
19-Jun-19 6:29 PM
View: 
Urovant Sciences Ltd. (UROV) 18-Jun-19Market Purchase (Planned)
Duplicate
6,706$8.21$55,061.00< 1%
22.85M to 22.86M
(8%)
19-Jun-19 6:29 PM
View: 
Urovant Sciences Ltd. (UROV) 17-Jun-19Market Purchase (Planned)
Duplicate
6,541$8.53$55,824.80< 1%
22.84M to 22.85M
(12%)
14-Jun-19 6:16 PM
View: 
Urovant Sciences Ltd. (UROV) 14-Jun-19Market Purchase (Planned)
Duplicate
7,144$7.91$56,514.00< 1%
22.83M to 22.84M
(5%)
14-Jun-19 6:16 PM
View: 
Urovant Sciences Ltd. (UROV) 13-Jun-19Market Purchase (Planned)
Duplicate
7,367$7.95$58,542.60< 1%
22.83M to 22.83M
(5%)
14-Jun-19 6:16 PM
View: 
Urovant Sciences Ltd. (UROV) 12-Jun-19Market Purchase (Planned)
Duplicate
7,500$8.30$62,244.00< 1%
22.82M to 22.83M
(9%)
11-Jun-19 6:14 PM
View: 
Urovant Sciences Ltd. (UROV) 11-Jun-19Market Purchase (Planned)
Duplicate
7,189$8.58$61,693.80< 1%
22.81M to 22.82M
3%
11-Jun-19 6:14 PM
View: 
Urovant Sciences Ltd. (UROV) 10-Jun-19Market Purchase (Planned)
Duplicate
7,500$8.35$62,594.20< 1%
22.81M to 22.81M
5%
11-Jun-19 6:14 PM
View: 
Urovant Sciences Ltd. (UROV) 07-Jun-19Market Purchase (Planned)
Duplicate
6,649$7.97$52,959.30< 1%
22.8M to 22.81M
10%
06-Jun-19 6:16 PM
View: 
Urovant Sciences Ltd. (UROV) 06-Jun-19Market Purchase (Planned)
Duplicate
7,082$8.00$56,621.30< 1%
22.79M to 22.8M
(5%)
06-Jun-19 6:16 PM
View: 
Urovant Sciences Ltd. (UROV) 05-Jun-19Market Purchase (Planned)
Duplicate
6,540$8.02$52,418.10< 1%
22.78M to 22.79M
(5%)
06-Jun-19 6:16 PM
View: 
Urovant Sciences Ltd. (UROV) 04-Jun-19Market Purchase (Planned)
Duplicate
7,500$7.59$56,910.80< 1%
22.78M to 22.78M
< 1%
13-Jun-19 3:45 PM
View: 
Myovant Sciences Ltd. (MYOV) 04-Jun-19Private Purchase
Duplicate
2,424,240$8.25$20,000,000.006%
38.34M to 40.77M
03-Jun-19 6:23 PM
View: 
Urovant Sciences Ltd. (UROV) 03-Jun-19Market Purchase (Planned)
Duplicate
5,424$7.71$41,814.70< 1%
22.77M to 22.78M
(3%)
03-Jun-19 6:23 PM
View: 
Urovant Sciences Ltd. (UROV) 31-May-19Market Purchase (Planned)
Duplicate
5,071$7.70$39,042.10< 1%
22.77M to 22.77M
(3%)
03-Jun-19 6:23 PM
View: 
Urovant Sciences Ltd. (UROV) 30-May-19Market Purchase (Planned)
Duplicate
7,251$8.01$58,089.50< 1%
22.76M to 22.77M
(7%)
29-May-19 6:23 PM
View: 
Urovant Sciences Ltd. (UROV) 29-May-19Market Purchase (Planned)
Duplicate
6,882$7.55$51,983.20< 1%
22.75M to 22.76M
(< 1%)
29-May-19 6:23 PM
View: 
Urovant Sciences Ltd. (UROV) 28-May-19Market Purchase (Planned)
Duplicate
3,807$7.68$29,244.60< 1%
22.75M to 22.75M
(2%)
29-May-19 6:23 PM
View: 
Urovant Sciences Ltd. (UROV) 24-May-19Market Purchase (Planned)
Duplicate
3,796$7.70$29,233.40< 1%
22.75M to 22.75M
(3%)
23-May-19 6:36 PM
View: 
Urovant Sciences Ltd. (UROV) 23-May-19Market Purchase (Planned)
Duplicate
4,802$7.76$37,252.00< 1%
22.74M to 22.75M
(2%)
23-May-19 6:36 PM
View: 
Urovant Sciences Ltd. (UROV) 22-May-19Market Purchase (Planned)
Duplicate
5,033$8.06$40,557.90< 1%
22.74M to 22.74M
(5%)
23-May-19 6:36 PM
View: 
Urovant Sciences Ltd. (UROV) 21-May-19Market Purchase
Duplicate
9,995$8.52$85,108.40< 1%
22.73M to 22.74M
(11%)
20-May-19 9:23 PM
View: 
Urovant Sciences Ltd. (UROV) 20-May-19Market Purchase
Duplicate
10,000$8.05$80,524.80(100%)
(-10.0K) to 0
(5%)
20-May-19 9:23 PM
View: 
Urovant Sciences Ltd. (UROV) 17-May-19Market Purchase
Duplicate
6,200$7.36$45,641.30(100%)
(-6.2K) to 0
4%
20-May-19 9:23 PM
View: 
Urovant Sciences Ltd. (UROV) 16-May-19Market Purchase
Duplicate
5,408$6.79$36,718.20< 1%
22.7M to 22.71M
12%
19-Mar-19 5:06 PM
View: 
Axovant Gene Therapies Ltd. (AXGT) 18-Mar-19Market Purchase
Duplicate
6,666,670$1.50$10,000,000.007%
99.29M to 105.95M
20-Dec-18 9:38 AM
View: 
Axovant Gene Therapies Ltd. (AXGT) 18-Dec-18Market Purchase
Duplicate
10,000,000$1.00$10,000,000.0011%
89.29M to 99.29M
< 1%
03-Oct-18 5:52 PM
View: 
Urovant Sciences Ltd. (UROV) 01-Oct-18Purchase
Duplicate
2,678,570$14.00$37,500,000.0013%
20.03M to 22.7M
07-Jun-18 8:21 AM
View: 
Axovant Gene Therapies Ltd. (AXGT) 05-Jun-18Market Purchase
Duplicate
14,285,700$1.75$25,000,000.0019%
75.0M to 89.29M
(43%)
04-Apr-18 9:58 PM
View: 
Myovant Sciences Ltd. (MYOV) 02-Apr-18Market Purchase
Duplicate
1,110,020$20.27$22,500,000.003%
37.23M to 38.34M
5%
08-Feb-16 9:43 PM
View: 
Editas Medicine, Inc. (EDIT) 08-Feb-15Conversion
Duplicate
1,709,400----44%
3.93M to 5.64M
08-Feb-16 9:43 PM
View: 
Editas Medicine, Inc. (EDIT) 08-Feb-15Conversion 1,709,400----30%
5.64M to 7.35M
08-Feb-16 9:43 PM
View: 
Editas Medicine, Inc. (EDIT) 08-Feb-15Purchase
Duplicate
1,020,410----14%
7.35M to 8.37M
08-Feb-16 9:43 PM
View: 
Editas Medicine, Inc. (EDIT) 08-Feb-15Purchase 1,020,410----12%
8.37M to 9.39M
08-Oct-14 6:32 PM
View: 
Wayfair Inc. (W) 02-Oct-14Purchase
Duplicate
479,250----18%
2.69M to 3.17M
08-Oct-14 6:32 PM
View: 
Wayfair Inc. (W) 02-Oct-14Purchase 373,789----12%
3.17M to 3.55M